Acute exacerbation of systemic scleroderma in Borrelia burgdorferi infection

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue 1, 2005, Pages 93-96

  Wackernagel, A ^a   Bergmann, A R ^a   Aberer, Elisabeth ^a  

^a Universitatsklinik fur Dermatologie und Venerologie   (Austria)

Author keywords

B. burgdorferi; Ceftriaxone; Systemic scleroderma; Urine PCR

Indexed keywords

CEFTRIAXONE; CENTROMERE ANTIBODY; NIFEDIPINE; PREDNISOLONE;

ADULT; ANAMNESIS; ARTICLE; BORRELIA BURGDORFERI; BORRELIA INFECTION; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; FACE DISORDER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; IMMUNOBLOTTING; LABORATORY TEST; LYME DISEASE; NAIL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SKIN BIOPSY; SKIN EDEMA; SKIN INDURATION; SKINFOLD; SYSTEMIC SCLEROSIS; TELANGIECTASIA; TRUNK; URINALYSIS;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYME DISEASE; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 13944251083     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.01074.x     Document Type: Article

References (9)

1. Tu JH, Eisen AZ. Scleroderma. In: Freedberg IM, Eisen AZ, Wolff K et al., eds. Fitzpatrick's Dermatology in General Medicine, 5th edn. McGraw-Hill, New York, 1993: 2023-2033.
2. Rowell NR, Goodfield MJD. Connective tissue diseases. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Rook, Wilkinson, Ebling. Textbook of Dermatology, 6th edn. Blackwell Science, Oxford, 1998: 2520-2544.
3. Detmar U, Maciejewski W, Link C et al. Unusual manifestations of Lyme borreliosis. A contribution to the clinical spectrum of this disease group. Hautarzt 1989; 40: 423-429.
4. Hoffmann JC, Stichtenoth DO, Zeidler H et al. Lyme disease in a 74-year-old forest owner with symptoms of dermatomyositis. Arthr Rheum 1995; 38: 1157-1160.
5. Fraser DD, Kong LI, Miller FW. Molecular detection of persistent B. burgdorferi in a man with dermatomyositis. Clin Exp Rheumatol 1992; 10: 387-390.
6. Weidenthaler B, Roux M, Moter SE et al. Sclerodermiform skin changes in Borrelia burgdorferi infection. Diagnostic use of polymerase chain reaction. Hautarzt 1994; 45: 171-175.
7. Bergmann AR, Schmidt BL, Derler AM, Aberer E. Importance of sample preparation for the molecular diagnosis of Lyme borreliosis from urine. J Clin Microbiol 2002; 40: 4581-4584.
8. Fujiwara H, Fujiwara K, Hashimoto K et al. Detection of Borrelia burgdorferi DNA (B. garinii or B. aftelii) in morphea and lichen sclerosus and atrophicus tissues of German and Japanese but not of US patients. Arch Dermatol 1997; 133: 41-44.
9. Breier FH, Aberer E, Stanek G et al. Isolation of Borrelia afzelii from circumscribed scleroderma. Br J Dermatol 1999; 140: 925-930.